Samsara Operating Cash Flow increased by 9.5% to $69.73M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 29.5%, from $53.86M to $69.73M. Over 4 years (FY 2022 to FY 2026), Operating Cash Flow shows an upward trend with a 8.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$37.07M | -$44.84M | -$41.26M | -$48.31M | -$48.78M | -$36.98M | -$12.89M | -$4.37M | $10.45M | $7.72M | $11.89M | -$41.88M | $23.67M | $18.12M | $36.01M | $53.86M | $52.61M | $50.16M | $63.70M | $69.73M |
| QoQ Change | — | -21.0% | +8.0% | -17.1% | -1.0% | +24.2% | +65.1% | +66.1% | +339.1% | -26.2% | +54.0% | -452.2% | +156.5% | -23.5% | +98.8% | +49.6% | -2.3% | -4.7% | +27.0% | +9.5% |
| YoY Change | — | — | — | — | -31.6% | +17.5% | +68.8% | +90.9% | +121.4% | +120.9% | +192.2% | -857.6% | +126.4% | +134.7% | +202.9% | +228.6% | +122.3% | +176.9% | +76.9% | +29.5% |